Andersons pediatric cardiology 243
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.64 KB, 3 trang )
inflammationandfibrosis.JLeukocBiol.
2003;74(6):959–960.
85.JaeggiET,FouronJC,SilvermanED,etal.
Transplacentalfetaltreatmentimprovesthe
outcomeofprenatallydiagnosedcomplete
atrioventricularblockwithoutstructuralheart
disease.Circulation.2004;110(12):1542–1548.
86.GrovesAM,AllanLD,RosenthalE.Outcomeof
isolatedcongenitalcompleteheartblock
diagnosedinutero.Heart.1996;75(2):190–194.
87.LopesLM,TavaresGM,DamianoAP,etal.
Perinataloutcomeoffetalatrioventricularblock:
one-hundred-sixteencasesfromasingle
institution.Circulation.2008;118(12):1268–
1275.
88.EliassonH,SonessonSE,SharlandG,etal.
Isolatedatrioventricularblockinthefetus:a
retrospective,multinational,multicenterstudyof
175patients.Circulation.2011;124(18):1919–
1926.
89.VandenBergNW,SliekerMG,vanBeynumIM,
etal.Fluorinatedsteroidsdonotimprove
outcomeofisolatedatrioventricularblock.IntJ
Cardiol.2016;225:167–171.
90.WaltuckJ,BuyonJP.Autoantibody-associated
congenitalheartblock:outcomeinmothersand
children.AnnInternMed.1994;120(7):544–551.
91.UdinktenCateFE,BreurJM,CohenMI,etal.
Dilatedcardiomyopathyinisolatedcongenital
completeatrioventricularblock:earlyandlongtermriskinchildren.JAmCollCardiol.
2001;37(4):1129–1134.
92.TruccoSM,JaeggiE,CuneoB,etal.Useof
intravenousgammaglobulinandcorticosteroids
inthetreatmentofmaternalautoantibodymediatedcardiomyopathy.JAmCollCardiol.
2011;57(6):715–723.
93.LevesqueK,MorelN,MaltretA,etal.
Descriptionof214casesofautoimmune
congenitalheartblock:resultsoftheFrench
neonatallupussyndrome.AutoimmunRev.
2015;14(12):1154–1160.
94.HutterD,SilvermanED,JaeggiET.Thebenefits
oftransplacentaltreatmentofisolatedcongenital
completeheartblockassociatedwithmaternal
anti-ro/SSAantibodies:areview.ScandJ
Immunol.2010;72(3):235–241.
95.SaleebS,CopelJ,FriedmanD,BuyonJP.
Comparisonoftreatmentwithfluorinated
glucocorticoidstothenaturalhistoryof
autoantibody-associatedcongenitalheartblock:
retrospectivereviewoftheresearchregistryfor
neonatallupus.ArthritisRheum.
1999;42(11):2335–2345.
96.SonessonSE,SalomonssonS,JacobssonLA,
BremmeK,Wahren-HerleniusM.Signsoffirstdegreeheartblockoccurinone-thirdoffetuses
ofpregnantwomenwithanti-SSA/ro52-kd
antibodies.ArthritisRheum.2004;50(4):1253–
1261.
97.RosenthalD,FriedmanDM,BuyonJ,DubinA.
ValidationofthedopplerPRintervalinthe
fetus.JAmSocEchocardiogr.2002;15(9):1029–
1030.
98.RaboissonMJ,FouronJC,SonessonSE,etal.
Fetaldopplerechocardiographicdiagnosisand
successfulsteroidtherapyofLucianiwenckebachphenomenonandendocardial
fibroelastosisrelatedtomaternalanti-roand
anti-laantibodies.JAmSocEchocardiogr.
2005;18(4):375–380.
99.BuyonJP,SwerskySH,FoxHE,BiermanFZ,
WinchesterRJ.Intrauterinetherapyfor
presumptivefetalmyocarditiswithacquired
heartblockduetosystemiclupuserythematosus.
Experienceinamotherwithapredominanceof
SS-B(La)antibodies.ArthritisRheum.
1987;30(1):44–49.
100.BiermanFZ,BaxiL,JaffeI,DriscollJ.Fetal
hydropsandcongenitalcompleteheartblock:
responsetomaternalsteroidtherapy.JPediatr.
